Impact of Electronic Cigarettes on Perinatal Immune Responsiveness and Birth Outcomes
Completed
Conditions studied: Immune Response, Birth Weight, Gestational Age
In brief
There has been a dramatic escalation of electronic cigarette (e-cig) use among women of childbearing age, including pregnant women. The overall goal of this study is to determine the effects of e-cigs on prenatal biomarkers and birth outcomes. It is imperative that more data about these effects be available to better inform women of childbearing age.
Key facts
- Study ID
- NCT02553577
- Run by
- Kristin Ashford
- People needed
- 278
- Starts
- 2016-01-13
- Expected to finish
- 2021-02-28
- Last updated by the study team
- 2021-07-07
Who can join
Age: 18 and older, up to 44. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- current tobacco use (traditional cigarettes and/or electronic cigarettes ecig, ENDS)
- pregnant in the first or second trimester
- age 18-44
- can read and write in English.
Where it is running
- University of Kentucky Prenatal Clinics, Good Samaritian and Polk Dalton — Lexington, Kentucky, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.